A phase I trial of c-Raf kinase antisense oligonucleotide ISIS 5132 administered as a continuous intravenous infusion in patients with advanced cancer. (Q40621340)
Jump to navigation
Jump to search
scientific article published on May 2000
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | A phase I trial of c-Raf kinase antisense oligonucleotide ISIS 5132 administered as a continuous intravenous infusion in patients with advanced cancer. |
scientific article published on May 2000 |
Statements
A phase I trial of c-Raf kinase antisense oligonucleotide ISIS 5132 administered as a continuous intravenous infusion in patients with advanced cancer (English)
Cunningham CC
Holmlund JT
Schiller JH
Geary RS
Kwoh TJ
Dorr A